Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
03/07/1990 | EP0357332A2 Renin inhibitors useful for the treatment of aids by inhibition of HIV protease |
03/07/1990 | EP0357030A2 Use of thromboxane A2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries |
03/07/1990 | CN1040202A Process for preparing dna polyanion platinum (ii) derivatives |
03/06/1990 | US4906638 Dextromethorphan potentiator for anticonvulsant composition and method |
03/06/1990 | US4906625 Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same |
03/06/1990 | US4906613 Antiglaucoma compositions and methods |
02/28/1990 | EP0355279A2 Use of nitrogen-containing compounds as antiparasitics, and compositions containing them |
02/28/1990 | EP0355245A1 Use of retrovirus reverse transcriptase inhibiting agents |
02/28/1990 | EP0355131A1 Acyl deoxyribonucleoside derivatives and uses thereof |
02/27/1990 | US4904479 Collidal particles coated with hydrophilic compound |
02/27/1990 | US4904467 Stabilized interleukin-2 |
02/27/1990 | CA1266232A1 Method of conferring immuno-tolerance to a specific antigen |
02/22/1990 | WO1990001339A1 Detection and treatment of infectious and inflammatory lesions |
02/22/1990 | WO1990001338A1 Leukocyte adhesion inhibitor |
02/22/1990 | WO1990001326A1 Preparation and use of a physiologically active polypeptide for treating aids |
02/22/1990 | WO1990001271A1 Process for producing antioxidant, biologically active extracts and oily, greasy compositions rich in vitamins and their use as an active ingredient of industrial, therapeutic and cosmetic preparations, as well as an active ingredient added to nutrients and to fodder |
02/21/1990 | EP0354921A1 Compositions and methods of effecting contraception and control of breast cancer. |
02/20/1990 | US4902680 Gonadotrophin, hormones |
02/20/1990 | US4902505 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
02/20/1990 | US4902501 Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them |
02/15/1990 | DE3827490A1 Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie Fitting and use of a physiologically active polypeptide for AIDS-therapy |
02/15/1990 | DE3826963A1 Pharmaceutical composition for oral administration containing metal complexing agents and metal salts |
02/15/1990 | DE3826962A1 Pharmaceutical composition for oral administration containing non-absorbable metal complexing agents |
02/13/1990 | US4900749 Isoprenoidamine compounds useful as antiulcer agents |
02/13/1990 | US4900735 Beta adrenergic and steroid for animal weight increase |
02/13/1990 | US4900723 In mammals, following surgery |
02/13/1990 | US4900720 Plasmapheresis |
02/13/1990 | CA1265747A1 Anesthetic methods for mammals |
02/08/1990 | WO1990000903A1 Method and compositions for the treatment and prevention of septic shock |
02/08/1990 | WO1990000899A1 Compositions and methods for treating skin conditions and promoting wound healing |
02/07/1990 | EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions |
02/07/1990 | EP0353262A1 New therapeutical use of h 2?-receptor-blocking compounds |
02/07/1990 | CN1039358A Process for preparing sinergistic composition |
02/06/1990 | US4898857 Treating control nervous system diseases |
02/06/1990 | US4898856 Method for treating central nervous system diseases |
01/30/1990 | US4897403 Verapamil and chloroquine |
01/30/1990 | US4897394 Antiviral combinations |
01/30/1990 | US4897389 Using estrogenic hormones |
01/30/1990 | CA1265009A1 Initiating reperfusion treatment when heart attack symptoms are present |
01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
01/25/1990 | WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use |
01/24/1990 | EP0351897A2 Skin penetration system for salts of amine-functional drugs |
01/24/1990 | EP0351767A2 Use of potassium channel activators to inhibit myocardial cell necrosis and to maintain the functioning of the heart during myocardial ischemia and/or reperfusion |
01/24/1990 | EP0351755A1 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination |
01/24/1990 | EP0351698A1 Synergistic pharmaceutical composition with an antimicrobial action and process for preparing same |
01/23/1990 | US4895845 Reserpine and trazodone, bupropion or fluoxetine antidepressant |
01/23/1990 | US4895726 Anticholesterol, antilipemic, micronized with surfactant |
01/23/1990 | CA1264667A1 Process for the preparation of prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units |
01/17/1990 | EP0351017A2 Pharmaceutical composition useful for the treatment of cardiovascular diseases |
01/17/1990 | EP0350973A1 Means and product for the diagnosis and therapy of tumours and for the treatment of weaknesses of the cellular and humoral immune system |
01/16/1990 | US4894454 Pharmaceutical preparations |
01/16/1990 | US4894443 Polypeptides, antibodies |
01/16/1990 | US4894373 Antiestrogens and their use in treatment of menopause and osteoporosis |
01/16/1990 | US4894225 Combination therapy using antitumor immunotoxins with tumor necrosis factor |
01/11/1990 | WO1990000061A1 Method for the treatment and the diagnosis of coronary heart disease |
01/11/1990 | WO1990000055A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
01/10/1990 | EP0350230A2 Immunoconjugates for cancer diagnosis and therapy |
01/10/1990 | CN1038585A Clear away heart-fire liquid and process for preparing same |
01/03/1990 | EP0349243A2 Antiviral combinations and compounds therefor |
01/02/1990 | US4891356 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
01/02/1990 | US4891226 Pharmaceutical which can be administered nasally, a process for its preparation, and its use |
12/28/1989 | WO1989012463A1 Method and therapeutic compositions for the treatment of myocardial infarction |
12/28/1989 | WO1989012459A1 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
12/27/1989 | EP0348290A2 Activated killer monocytes : tumoricidal activity and method of monitoring same |
12/27/1989 | EP0347864A2 Anti-atherogenic agents |
12/20/1989 | EP0347057A1 Method of treating myeloid leukemias |
12/20/1989 | EP0346451A1 Antiviral activity of fatty acids and monoglycerides |
12/20/1989 | EP0346445A1 Dextrorphan potentiator for anticonvulsant composition and method |
12/20/1989 | EP0174342B1 Brain-specific analogues of centrally acting amines |
12/19/1989 | US4888354 Skin penetration enhancement using free base and acid addition salt combinations of active agents |
12/19/1989 | US4888331 Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction |
12/14/1989 | WO1989011869A1 Antibody modified with toxin |
12/14/1989 | WO1989011867A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
12/14/1989 | WO1989011864A1 Method of treating myeloid leukemias |
12/14/1989 | WO1989011861A1 Derivatives of platinum (p) with polyanion of deoxyribonucleic acid, method for obtaining them and pharmaceutical antitumor preparation based on them |
12/14/1989 | WO1989011860A1 Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection |
12/14/1989 | WO1989011854A1 Pharmacological treatment of ocular development |
12/14/1989 | WO1989011853A1 Use of local anaesthetic agents in the manufacture of preparations with wound healing effect |
12/14/1989 | WO1989011851A1 Treatment of inflammatory diseases, in particular rheumatoid arthritis |
12/14/1989 | WO1989011850A1 Method for making solvent dilution microcarriers |
12/13/1989 | EP0346014A1 Therapeutic product for the treatment of peri- or postmenopausal conditions |
12/13/1989 | EP0345948A2 Use of 5-HT1A agonists for the manufacture of a medicament protecting against ischaemic damage |
12/13/1989 | EP0345931A1 Certain PAF antagonist/antihistamine combinations and methods |
12/13/1989 | EP0345304A1 Pharmaceutical compositions |
12/13/1989 | EP0345302A1 Liposomal vesicles for intraperitoneally administering therapeutic agents |
12/12/1989 | US4886789 Peritoneal dialysis and compositions for use therein |
12/06/1989 | EP0345068A2 Agonist of gamma-aminobutyric acid |
12/06/1989 | EP0344586A2 Medicine containing a TNF inhibitor |
12/06/1989 | EP0344572A2 Composition of angiotensin-converting-enzyme inhibitor with calcium chanell modulators and uses thereof as pharmaceuticals |
12/05/1989 | US4885154 Coadministering a metabolic modulator |
11/30/1989 | WO1989011538A1 Platelet-specific chimeric immunoglobulin |
11/30/1989 | WO1989011487A1 Derivatives of cyclic amp as treatment for cancer |
11/30/1989 | WO1989011295A1 Inhibition of lipogenesis |
11/30/1989 | WO1989011287A1 Induction of tolerance to a foreign antigen |
11/30/1989 | WO1989011285A1 Diagnostics and therapy for rheumatoid arthritis |
11/30/1989 | WO1989011274A1 Chemotherapeutic composition for aids |
11/30/1989 | WO1989011269A1 Delayed release formulations |
11/29/1989 | EP0343993A1 Delayed release formulations |
11/29/1989 | EP0343671A2 Pharmaceutical composition for the treatment of skin wounds |
11/28/1989 | US4883803 Treatment of anxiety |